MedTrace Logo

Lipidomics and Functional Analyses of Platelets in Fabry Disease

NCT02649660 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2017-05-08

No results posted yet for this study

Summary

This study aims to evaluate whether platelets are biochemically and functionally altered in Fabry disease (FD) and therefore possibly implicated in FD manifestations such as cerebrovascular events. To test this hypothesis the investigators aim to compare platelet and plasma lipid profiles, as well as platelet function and coagulation parameters of FD patients and healthy controls.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Pierre-Alexandre Krayenbühl, MD · Spital Linth

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02649660 on ClinicalTrials.gov